| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919425 | Radiotherapy and Oncology | 2011 | 6 Pages |
Abstract
miR-210 could be an interesting marker of chronic hypoxia irrespective of the androgen dependency and should, therefore, be tested as a prognostic marker in high risk prostate cancer patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Laurent Quero, Ludwig Dubois, Natasja G. Lieuwes, Christophe Hennequin, Philippe Lambin,